QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma
Clinical trial NCT01029873 · COMPLETED
Trial details
- NCT number
- NCT01029873
- Sponsor
- Altor BioScience
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-11-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.